Navigation Links
Can Implanon® (Etonogestrel Implant) Go Missing? Zoll, Kranz & Borgess, LLC Files Another Lawsuit on Behalf of Women with Lost or Migrated Implanon® Implants

Recently, ZKB filed another federal lawsuit in the U.S. District Court for the Northern District of Ohio, Western Division (Case No. 3:15-cv-00397) involving the Implanon® contraceptive implant.

As described in the complaint (Case No: 3:15-cv-00397), the women experienced spontaneous migration of their Implanon® implants, inability to locate the implants, unsuccessful and invasive attempts at implant removal, and inability to remove the lost implants. As a result of their lost, irretrievable and irreversible implants, the complaint describes that these women are now at risk for infertility, ectopic pregnancy, the inability to stop a drug-related adverse event, neural and vascular damage and other potential injuries.

Implanon® is a single rod contraceptive implant containing etonogestrel, a synthetic progestin. The federal Food and Drug Administration (FDA) approved Implanon® in July 2006.

The complaint alleges that Merck knew or should have known that Implanon® could spontaneously migrate after insertion and that because Implanon® is not radiopaque there may be no way to locate a lost implant with imaging technologies once it has migrated.

Despite this knowledge, the complaint alleges that Merck failed to make Implanon® radiopaque, and further failed to warn women and their doctors of this issue. Instead, Merck allegedly continued to aggressively promote and market the non-radiopaque Implanon® as safe, “reversible,” and able to be removed whenever the patient “change[s] [her] mind.”

While continuing to aggressively promote and market non-radiopaque Implanon®, the complaint states that Merck developed the bio-equivalent Nexplanon® to address Implanon®’s defects. Although bio-equivalent, Nexplanon® is radiopaque so that it can be found using imagining technologies and has a re-designed insertion applicator intended to ensure an optimal subdermal location. Yet, during this time and even after Nexplanon®’s approval, Merck did not pull Implanon® from the market or warn women or their doctors of Implanon®’s risks.

The law firm of Zoll, Kranz & Borgess, LLC (“ZKB”) devotes its practice to the field of pharmaceutical and medical device litigation. ZKB is dedicated to compelling companies to produce safer products. Injured clients and partnering attorneys from across the U.S. appreciate and rely upon over 70 years of combined experience in pharmaceutical mass torts and multidistrict litigation. ZKB’s experienced team includes a practicing physician-attorney and all the technology, knowledge and experience necessary to succeed in this complex legal field. For more information about Implanon®, contact ZKB toll-free at (888) 841-9623 or visit the firm’s website at Initial consultations are always free and confidential.

Read the full story at

Source: PRWeb
Copyright©2015 Vocus, Inc.
All rights reserved

Related medicine news :

1. Judge Kennelly Appoints Attorney Michelle Kranz to the Plaintiffs’ Executive Committee in the Testosterone Replacement Therapy MDL
2. Absolute PhysioCare & Sports Rehab Promotes Understanding & Treatment of Ankle Sprains
3. Heels & Wheels for Megan's House Set for Saturday August 22, 2015 in Waycross, Georgia
4. The Venetian on Grace Bay in Turks & Caicos Islands Offers 40% Savings This Fall.
5. Bill Howe Plumbing, Heating & Air Launches Online Application to Prospective Employees
6. 21 Years & Counting: The USC Eye Institute Ranks in the Top 10 Ophthalmology Hospitals in America
7. Gina Powers Named Vice President & General Manager of ITW Dynatec
8. CareMed Urgent & Primary Care Supports National Immunization Awareness Month
9. Flute Meditations for Yoga & Massage: Calming Spa Music for Relaxation & Sleep by Gary Stroutsos
10. Maryland Brain & Spine Announces New Specialty, New Name
11. Piedmont Physical Medicine & Rehabilitation, P.A. Partners with Realief® Neuropathy Centers to Offer Peripheral Neuropathy Laser Treatment
Post Your Comments:
(Date:4/7/2020)... ... April 07, 2020 , ... Black Jaguar-White Tiger Foundation, ... pets. The new range, Black Jaguar-White Tiger Hemp consists of a chewable tablet and ... and animal product the foundation has launched. , “It is my great Honor, to ...
(Date:4/5/2020)... ... April 04, 2020 , ... MyAdvisor, a holistic wellness technology ... Yellow Ribbon Fund (YRF) to offer mental health and care coordination services to ... partnership to launch a new initiative throughout the global COVID-19 pandemic, MyAdvisor and ...
(Date:4/2/2020)... ... 02, 2020 , ... FDA CDS Software Regulation:, The Latest ... 1:30-3:00 p.m. EDT, , *NEW: The webinar ... management of the Coronavirus.* , Is one’s software regulated as a medical device? ...
(Date:4/2/2020)... , ... April 02, 2020 , ... ... in their mother’s womb are encouraging their parents, grandparents, and guardians, to file ... up to $6 billion in funds will be made available by Purdue as ...
(Date:4/1/2020)... (PRWEB) , ... April 01, 2020 , ... ... equipment (PPE) to stay safe while treating Coronavirus-infected patients. , Staffers are in ... that can transmit coronavirus. Earlier this week, The Wall Street Journal reported that ...
Breaking Medicine News(10 mins):
(Date:4/2/2020)... Wis. (PRWEB) , ... April 02, 2020 , ... ... temporary hospitals, Kenall introduces the KRT Series, a portable, durable luminaire using Indigo-Clean ... killing harmful bacteria, bolstering existing cleaning and infection prevention protocols, and reducing harmful ...
(Date:4/1/2020)... , ... April 01, 2020 , ... Care Station Medical ... Group has implemented a number of changes to better care for our community. As ... our office hours and crafted new ways to offer medical care to patients coping ...
(Date:4/1/2020)... ... April 01, 2020 , ... ... sign up today, with the first live-streaming broadcast premiering on April 2. , ... a host interviewing a variety of animal keepers and veterinary hospital staff with ...
Breaking Medicine Technology: